ALXN - Alexion Pharmaceuticals Inc (ALXN) CEO Ludwig Hantson on Q4 2019 Results - Earnings Call Transcript
Alexion Pharmaceuticals Inc (ALXN)
Q4 2019 Earnings Conference Call
January 30, 2020 07:30 AM ET
Company Participants
Morgan Sanford - Director of Investor Relations
Ludwig Hantson - Chief Executive Officer
Aradhana Sarin - Chief Financial Officer
John Orloff - Global Head of R&D
Brian Goff - Chief Commercial and Global Operations Officer
Conference Call Participants
Cory Kasimov - JP Morgan
Geoff Meacham - Bank of America
Geoffrey Porges - SVB Leerink
Chris Raymond - Piper Sandler
Josh Schimmer - Evercore
Kostas Biliouris - Morgan Stanley
Robyn Karnauskas - SunTrust Robinson
Mohit Bansal - Citigroup
Kennen